Indications
Treatment of non ketotic hyperglycinemia, urea cycle disorders including carbamoyl-phosphate synthase-1 deficiency, ornithine transcarbamylase deficiency, citrullinaemia type 1, argininosuccinic aciduria, hyperargininaemia, n-acetylglutamate synthase deficiency, ornithine translocase deficiency and lysinuric protein intolerance.
Composition
- Active substance
- sodium benzoate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Prohippur
- Active substance
- sodium benzoate
- ATC code
- A16AX11
- Therapeutic area
- Urea Cycle Disorders, Inborn, Hyperglycinemia, Nonketotic
- Marketing authorisation holder